Stratasys Releases Third Quarter 2022 Financial Results
Stratasys Ltd. (SSYS) reported a 2.0% rise in consolidated revenues for Q3 2022, totaling $162.2 million. Adjusted revenue increased by 7.8% on a constant currency basis. The company achieved a GAAP net income of $18.7 million ($0.28 per share) and improved non-GAAP operating income to $4.5 million. Despite an operating cash loss of $18.4 million due to inventory increases, the company maintains a solid cash position with $348.7 million and no debt. Full-year 2022 revenue guidance is updated to $648-$652 million, reflecting about 10% growth post-divestiture of MakerBot.
- Q3 2022 consolidated revenue rose 2.0% to $162.2 million.
- Non-GAAP operating income improved to $4.5 million from $1.8 million.
- Achieved five consecutive quarters of positive earnings.
- Full-year revenue guidance adjusted to $648-$652 million, representing approximately 10% growth.
- GAAP operating loss of $15.6 million, though improved from $21.9 million the prior year.
- Cash used in operating activities was $18.4 million, indicating liquidity concerns.
- Full-year net loss projected between $48 million and $39 million.
-
Consolidated Revenues grew
2.0% , and increased7.8% as adjusted for divestitures and on a constant currency basis -
Third quarter GAAP net income of
, or$18.7 million per diluted share, and non-GAAP net income of$0.28 , or$3.3 million per diluted share$0.05 -
of cash and cash equivalents and no debt at quarter end$348.7 million -
Updates 2022 full-year outlook reflecting approximately
10% revenue growth over 2021 adjusted for divestitures
Third Quarter 2022 Financial Results Compared to Third Quarter 2021:
-
Consolidated revenue of
, up$162.2 million 2.0% compared to ; adjusted revenue excluding divestitures and on a constant currency basis increased$159.0 million 7.8% . -
GAAP gross margin of
43.6% versus42.9% . -
Non-GAAP gross margin of
48.5% , compared to48.2% . -
GAAP operating loss of
, compared to a GAAP operating loss of$15.6 million .$21.9 million -
Non-GAAP operating income of
, versus non-GAAP operating income of$4.5 million .$1.8 million -
GAAP net income of
, or$18.7 million per diluted share, compared to net loss of$0.28 , or ($18.1 million ) per diluted share.$0.28 -
Non-GAAP net income of
, or$3.3 million per diluted share, versus non-GAAP net income of$0.05 , or$0.5 million per diluted share.$0.01 -
Adjusted EBITDA of
, compared to$9.9 million .$7.8 million -
of cash used by, compared to$18.4 million of cash generated from, operating activities, reflecting cash use for a continued augmentation of inventories.$3.0 million
Dr.
“As the leading provider of comprehensive polymer additive manufacturing products, software, and services solutions, we continue to enhance our core competencies and evolve our offerings to outpace our customers’ expanding needs. We are excited about the significant expansion of our materials portfolio across multiple technologies, which we believe will drive higher-margin consumables sales in the coming years. In addition, as part of our growth strategy we will keep selectively adding and incubating complementary new technology-driven businesses that we expect will spur incremental growth in the future.
Financial Outlook:
Based on current market conditions, and assuming that the collective impact of global supply chain costs, rising interest rates, currency risk and inflation does not further worsen economic activity, the Company is updating its outlook for 2022 to include the impact of
-
Full year 2022 revenue of
to$648 million , which includes the impact of approximately$652 million to reflect the anticipated impact of customer-related delays in the purchasing of systems and materials due to anticipated, ongoing economic uncertainty as well as ongoing pressure on foreign exchange rates. The updated outlook represents approximately$13 million 10% full year growth over 2021 after adjusting for the MakerBot divestiture. - Full-year 2022 gross margins flat to slightly higher compared to full-year 2021, based on current logistics and materials costs.
-
Full year-operating expenses
to$5 million higher than 2021, primarily due to the divestiture of MakerBot and by improved efficiencies.$10 million -
Full year non-GAAP operating margins slightly above
2% . -
GAAP net loss of
to$48 million , or ($39 million ) to ($0.72 ) per diluted share.$0.59 -
Non-GAAP net income of
to$6 million , or$8 million to$0.09 per diluted share.$0.12 -
Adjusted EBITDA of
to$34 million .$37 million -
Capital expenditures of
to$15 million .$20 million
Non-GAAP earnings outlook excludes
Appropriate reconciliations between GAAP and non-GAAP financial measures are provided in a table at the end of this press release and slide presentation, with itemized detail concerning the non-GAAP financial measures.
The Company plans to webcast its conference call to discuss its third quarter 2022 financial results on
The investor conference call will be available via live webcast on the
https://event.choruscall.com/mediaframe/webcast.html?webcastid=Aau6uFJK
To participate by telephone, the
To learn more about
Cautionary Statement Regarding Forward-Looking Statements
The statements in this press release regarding
Use of Non-GAAP Financial Measures
The non-GAAP data included herein, which exclude certain items as described below, are non-GAAP financial measures. Our management believes that these non-GAAP financial measures are useful information for investors and shareholders of our company in gauging our results of operations (i) on an ongoing basis after excluding mergers, acquisitions and divestments related expense or gains and reorganization-related charges or gains, legal provisions and currency-related fluctuations, and (ii) excluding non-cash items such as stock-based compensation expenses, acquired intangible assets amortization, including intangible assets amortization related to equity method investments, impairment of long-lived assets and goodwill, revaluation of our investments and the corresponding tax effect of those items. These factors eliminated in non-GAAP adjustments either do not reflect actual cash outlays that impact our liquidity and our financial condition or have a non-recurring impact on the statement of operations, as assessed by management. These non-GAAP financial measures are presented to permit investors to more fully understand how management assesses our performance for internal planning and forecasting purposes. The limitations of using these non-GAAP financial measures as performance measures are that they provide a view of our results of operations without including all items indicated above during a period, which may not provide a comparable view of our performance to other companies in our industry. Investors and other readers should consider non-GAAP measures only as supplements to, not as substitutes for or as superior measures to, the measures of financial performance prepared in accordance with GAAP. Reconciliation between results on a GAAP and non-GAAP basis is provided in a table below.
Consolidated Balance Sheets | ||||||||
(Unaudited) | ||||||||
(in thousands, except share data) | ||||||||
2022 |
2021 |
|||||||
ASSETS | ||||||||
Current assets | ||||||||
Cash and cash equivalents | $ |
150,672 |
|
$ |
243,179 |
|
||
Short-term deposits |
|
198,056 |
|
|
259,000 |
|
||
Accounts receivable, net of allowance for credit losses of |
|
140,258 |
|
|
129,382 |
|
||
Inventories |
|
170,434 |
|
|
129,147 |
|
||
Prepaid expenses |
|
8,146 |
|
|
6,871 |
|
||
Other current assets |
|
26,838 |
|
|
33,123 |
|
||
Total current assets |
|
694,404 |
|
|
800,702 |
|
||
Non-current assets | ||||||||
Property, plant and equipment, net |
|
194,214 |
|
|
203,295 |
|
||
|
64,844 |
|
|
65,144 |
|
|||
Other intangible assets, net |
|
129,682 |
|
|
152,244 |
|
||
Operating lease right-of-use assets |
|
19,010 |
|
|
14,651 |
|
||
Long-term investments |
|
143,928 |
|
|
28,667 |
|
||
Other non-current assets |
|
21,309 |
|
|
12,519 |
|
||
Total non-current assets |
|
572,987 |
|
|
476,520 |
|
||
Total assets | $ |
1,267,391 |
|
$ |
1,277,222 |
|
||
LIABILITIES AND EQUITY | ||||||||
Current liabilities | ||||||||
Accounts payable | $ |
67,957 |
|
$ |
51,976 |
|
||
Accrued expenses and other current liabilities |
|
55,152 |
|
|
55,358 |
|
||
Accrued compensation and related benefits |
|
34,862 |
|
|
44,684 |
|
||
Deferred revenues - short term |
|
48,735 |
|
|
51,174 |
|
||
Operating lease liabilities - short term |
|
6,977 |
|
|
7,276 |
|
||
Total current liabilities |
|
213,683 |
|
|
210,468 |
|
||
Non-current liabilities | ||||||||
Deferred revenues - long term |
|
23,581 |
|
|
21,133 |
|
||
Deferred income taxes - long term |
|
4,084 |
|
|
7,341 |
|
||
Operating lease liabilities - long term |
|
11,738 |
|
|
7,693 |
|
||
Contingent consideration - long term |
|
38,551 |
|
|
53,478 |
|
||
Other non-current liabilities |
|
27,028 |
|
|
21,095 |
|
||
Total non-current liabilities |
|
104,982 |
|
|
110,740 |
|
||
Total liabilities |
|
318,665 |
|
|
321,208 |
|
||
Equity | ||||||||
Ordinary shares, |
||||||||
shares; 66,784 thousands shares and 65,677 thousands shares issued | ||||||||
and outstanding at |
|
186 |
|
|
182 |
|
||
Additional paid-in capital |
|
3,037,225 |
|
|
3,012,481 |
|
||
Accumulated other comprehensive loss |
|
(14,223 |
) |
|
(8,771 |
) |
||
Accumulated deficit |
|
(2,074,462 |
) |
|
(2,047,878 |
) |
||
|
948,726 |
|
|
956,014 |
|
|||
Total liabilities and equity | $ |
1,267,391 |
|
$ |
1,277,222 |
|
||
Consolidated Statements of Operations | |||||||||||||||
(in thousands, except per share data) | |||||||||||||||
Three Months Ended |
Nine Months Ended |
||||||||||||||
2022 |
2021 |
2022 |
2021 |
||||||||||||
(unaudited) | (unaudited) | (unaudited) | (unaudited) | ||||||||||||
Net sales | |||||||||||||||
Products | $ |
112,133 |
|
$ |
108,888 |
|
$ |
340,927 |
|
$ |
299,517 |
|
|||
Services |
|
50,059 |
|
|
50,121 |
|
|
151,297 |
|
|
140,686 |
|
|||
|
162,192 |
|
|
159,009 |
|
|
492,224 |
|
|
440,203 |
|
||||
Cost of sales | |||||||||||||||
Products |
|
55,916 |
|
|
54,820 |
|
|
176,421 |
|
|
151,471 |
|
|||
Services |
|
35,527 |
|
|
36,001 |
|
|
107,984 |
|
|
101,697 |
|
|||
|
91,443 |
|
|
90,821 |
|
|
284,405 |
|
|
253,168 |
|
||||
Gross profit |
|
70,749 |
|
|
68,188 |
|
|
207,819 |
|
|
187,035 |
|
|||
Operating expenses | |||||||||||||||
Research and development, net |
|
23,145 |
|
|
22,645 |
|
|
71,489 |
|
|
65,683 |
|
|||
Selling, general and administrative |
|
63,230 |
|
|
67,462 |
|
|
195,085 |
|
|
184,353 |
|
|||
|
86,375 |
|
|
90,107 |
|
|
266,574 |
|
|
250,036 |
|
||||
Operating loss |
|
(15,626 |
) |
|
(21,919 |
) |
|
(58,755 |
) |
|
(63,001 |
) |
|||
Gain from deconsolidation of subsidiary |
|
39,136 |
|
|
- |
|
|
39,136 |
|
|
- |
|
|||
Financial income (expense), net |
|
452 |
|
|
(634 |
) |
|
(2,080 |
) |
|
(1,383 |
) |
|||
Income (loss) before income taxes |
|
23,962 |
|
|
(22,553 |
) |
|
(21,699 |
) |
|
(64,384 |
) |
|||
Income tax expense (benefit) |
|
3,298 |
|
|
699 |
|
|
2,796 |
|
|
6,009 |
|
|||
Share in profit (losses) of associated companies |
|
(1,915 |
) |
|
3,778 |
|
|
(2,089 |
) |
|
1,229 |
|
|||
Net income (loss) | $ |
18,749 |
|
$ |
(18,076 |
) |
$ |
(26,584 |
) |
$ |
(57,146 |
) |
|||
Net income (loss) per share | |||||||||||||||
Basic | $ |
0.28 |
|
$ |
(0.28 |
) |
$ |
(0.40 |
) |
$ |
(0.91 |
) |
|||
Diluted | $ |
0.28 |
|
$ |
(0.28 |
) |
$ |
(0.40 |
) |
$ |
(0.91 |
) |
|||
Weighted average ordinary shares outstanding | |||||||||||||||
Basic |
|
66,772 |
|
|
65,018 |
|
|
66,356 |
|
|
62,888 |
|
|||
Diluted |
|
67,038 |
|
|
65,018 |
|
|
66,356 |
|
|
62,888 |
|
|||
Three Months Ended |
|||||||||||||||||||||||
2022 |
Non-GAAP | 2022 |
2021 |
Non-GAAP | 2021 |
||||||||||||||||||
GAAP | Adjustments | Non-GAAP | GAAP | Adjustments | Non-GAAP | ||||||||||||||||||
Gross profit (1) | $ |
70,749 |
|
$ |
7,990 |
|
$ |
78,739 |
$ |
68,188 |
|
$ |
8,507 |
|
$ |
76,695 |
|||||||
Operating income (loss) (1,2) |
|
(15,626 |
) |
|
20,149 |
|
|
4,523 |
|
(21,919 |
) |
|
23,739 |
|
|
1,820 |
|||||||
Net income (loss) (1,2,3) |
|
18,749 |
|
|
(15,423 |
) |
|
3,326 |
|
(18,076 |
) |
|
18,592 |
|
|
516 |
|||||||
Net income (loss) per diluted share (4) | $ |
0.28 |
|
$ |
(0.23 |
) |
$ |
0.05 |
$ |
(0.28 |
) |
$ |
0.28 |
|
$ |
0.01 |
|||||||
(1) |
Acquired intangible assets amortization expense |
|
6,941 |
|
|
5,495 |
|
||||||||||||||||
Non-cash stock-based compensation expense |
|
1,061 |
|
|
804 |
|
|||||||||||||||||
Restructuring and other related costs |
|
(12 |
) |
|
67 |
|
|||||||||||||||||
Impairment charges |
|
- |
|
|
2,141 |
|
|||||||||||||||||
|
7,990 |
|
|
8,507 |
|
||||||||||||||||||
(2) |
Acquired intangible assets amortization expense |
|
2,138 |
|
|
2,205 |
|
||||||||||||||||
Non-cash stock-based compensation expense |
|
6,330 |
|
|
7,154 |
|
|||||||||||||||||
Impairment of long-lived assets |
|
- |
|
|
1,242 |
|
|||||||||||||||||
Restructuring and other related costs |
|
1,309 |
|
|
210 |
|
|||||||||||||||||
Revaluation of investments |
|
901 |
|
|
2,025 |
|
|||||||||||||||||
Contingent consideration |
|
394 |
|
|
197 |
|
|||||||||||||||||
Other expenses |
|
1,087 |
|
|
2,199 |
|
|||||||||||||||||
|
12,158 |
|
|
15,232 |
|
||||||||||||||||||
|
20,149 |
|
|
23,739 |
|
||||||||||||||||||
(3) |
Gain from deconsolidation of subsidiary |
|
(39,136 |
) |
|
- |
|
||||||||||||||||
Corresponding tax effect and other expenses |
|
3,564 |
|
|
(5,147 |
) |
|||||||||||||||||
$ |
(15,423 |
) |
$ |
18,592 |
|
||||||||||||||||||
(4) |
Weighted average number of ordinary shares outstanding - Diluted |
|
67,038 |
|
|
67,038 |
|
65,018 |
|
|
65,950 |
||||||||||||
Six Months Ended |
||||||||||||||||||||||||
2022 |
Non-GAAP | 2022 |
2021 |
Non-GAAP | 2021 |
|||||||||||||||||||
GAAP | Adjustments | Non-GAAP | GAAP | Adjustments | Non-GAAP | |||||||||||||||||||
Gross profit (1) | $ |
207,819 |
|
$ |
27,593 |
|
$ |
235,412 |
$ |
187,035 |
|
$ |
22,192 |
|
$ |
209,227 |
|
|||||||
Operating income (loss) (1,2) |
|
(58,755 |
) |
|
67,235 |
|
|
8,480 |
|
(63,001 |
) |
|
59,657 |
|
|
(3,344 |
) |
|||||||
Net income (loss) (1,2,3) |
|
(26,584 |
) |
|
32,295 |
|
|
5,711 |
|
(57,146 |
) |
|
52,284 |
|
|
(4,862 |
) |
|||||||
Net income (loss) per diluted share (4) | $ |
(0.40 |
) |
$ |
0.49 |
|
$ |
0.09 |
$ |
(0.91 |
) |
$ |
0.83 |
|
$ |
(0.08 |
) |
|||||||
(1) |
Acquired intangible assets amortization expense |
|
20,861 |
|
|
16,368 |
|
|||||||||||||||||
Non-cash stock-based compensation expense |
|
3,041 |
|
|
2,226 |
|
||||||||||||||||||
Restructuring and other related costs |
|
(174 |
) |
|
1,457 |
|
||||||||||||||||||
Impairment charges |
|
3,865 |
|
|
2,141 |
|
||||||||||||||||||
|
27,593 |
|
|
22,192 |
|
|||||||||||||||||||
(2) |
Acquired intangible assets amortization expense |
|
6,581 |
|
|
6,598 |
|
|||||||||||||||||
Non-cash stock-based compensation expense |
|
21,714 |
|
|
20,914 |
|
||||||||||||||||||
Impairment of long-lived assets |
|
- |
|
|
2,664 |
|
||||||||||||||||||
Restructuring and other related costs |
|
1,864 |
|
|
2,370 |
|
||||||||||||||||||
Revaluation of investments |
|
3,217 |
|
|
556 |
|
||||||||||||||||||
Contingent consideration |
|
1,197 |
|
|
590 |
|
||||||||||||||||||
Other expenses |
|
5,069 |
|
|
3,773 |
|
||||||||||||||||||
|
39,642 |
|
|
37,465 |
|
|||||||||||||||||||
|
67,235 |
|
|
59,657 |
|
|||||||||||||||||||
(3) |
Gain from deconsolidation of subsidiary |
|
(39,136 |
) |
|
- |
|
|||||||||||||||||
Corresponding tax effect and other expenses |
|
4,196 |
|
|
(7,373 |
) |
||||||||||||||||||
$ |
32,295 |
|
$ |
52,284 |
|
|||||||||||||||||||
(4) |
Weighted average number of ordinary shares outstanding - Diluted |
|
66,356 |
|
|
67,007 |
|
62,888 |
|
|
62,888 |
|
||||||||||||
Reconciliation of GAAP to Non-GAAP Forward Looking Guidance | ||
Fiscal Year 2022 | ||
(in millions, except per share data) | ||
GAAP net loss | ( |
|
Adjustments | ||
Stock-based compensation expense | ||
Intangible assets amortization expense | ||
Reorganization and other | ||
Tax expense (benefit) related to Non-GAAP adjustments | ||
Non-GAAP net income | ||
GAAP loss per share | ( |
|
Non-GAAP diluted earnings per share | ||
View source version on businesswire.com: https://www.businesswire.com/news/home/20221110005307/en/
CCO, VP Investor Relations
Yonah.Lloyd@stratasys.com
Source:
FAQ
What is Stratasys Ltd's Q3 2022 revenue growth rate?
What is the projected revenue for Stratasys in 2022?
How much cash does Stratasys have as of Q3 2022?
What was Stratasys's GAAP net income for Q3 2022?